
Align Technology Appoints Two New Directors to Board
Align Technology, Inc. announced the appointment of two new directors to its Board: Paul Clancy, effective immediately, and Ian Bell, effective December 10, 2026. The Board size will increase from 11 to 13 directors to accommodate these appointments. Both directors will participate in the company's non-employee director compensation program, with prorated retainers and equity grants. Clancy brings extensive financial and strategic leadership experience from the biopharmaceutical industry, having served as CFO for Alexion Pharmaceuticals and Biogen. Bell brings global healthcare, operational, and innovation leadership experience from Alcon Inc. Both are expected to stand for election at the May 2027 annual meeting.
Key Highlights
- Paul Clancy appointed to Align Technology Board of Directors, effective immediately.
- Ian Bell appointed to Align Technology Board of Directors, effective December 10, 2026.
- Board size increased from 11 to 12 directors upon Clancy's appointment.
- Board size further increased from 12 to 13 directors upon Bell's appointment.
- Messrs. Clancy and Bell to participate in the non-employee director compensation program.
- Annual retainer and equity grant will be prorated for both directors.
- Paul Clancy has over 30 years of experience in biotechnology and pharmaceutical industries.
- Ian Bell oversees commercial, manufacturing, quality, and regulatory operations at Alcon Inc.
Price Impact
More from ALGN